Antigen-presenting cell engineering. The molecular toolbox.
作者信息
Tykocinski M L, Kaplan D R, Medof M E
机构信息
Department of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, USA.
出版信息
Am J Pathol. 1996 Jan;148(1):1-16.
Abstract
摘要
相似文献
1
Antigen-presenting cell engineering. The molecular toolbox.抗原呈递细胞工程。分子工具箱。
Am J Pathol. 1996 Jan;148(1):1-16.
2
Tumour immunotherapy: the adjuvant treatment of the 21st century?肿瘤免疫疗法：21世纪的辅助治疗手段？
Eur J Surg Oncol. 2000 Jun;26(4):418-24. doi: 10.1053/ejso.1999.0908.
3
Quality and quantity: new strategies to improve immunotherapy of cancer.质量与数量：改善癌症免疫疗法的新策略
Trends Mol Med. 2004 May;10(5):205-8. doi: 10.1016/j.molmed.2004.03.004.
4
Genetically engineered fibroblasts with antigen-presenting capability: efficient induction of an antigen-specific cytotoxic T-lymphocyte response and protection against tumor development in vivo.具有抗原呈递能力的基因工程成纤维细胞：高效诱导抗原特异性细胞毒性T淋巴细胞反应并在体内预防肿瘤发生
Cancer Gene Ther. 2000 Jun;7(6):861-9. doi: 10.1038/sj.cgt.7700193.
5
On immunotherapies and cancer vaccination protocols: a mathematical modelling approach.关于免疫疗法和癌症疫苗接种方案：一种数学建模方法。
J Theor Biol. 2009 Aug 21;259(4):820-7. doi: 10.1016/j.jtbi.2009.05.001. Epub 2009 May 14.
6
Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.表达CD40配体的非复制型重组痘苗病毒可增强抗原呈递细胞刺激特异性CD4⁺和CD8⁺T细胞反应的能力。
Hum Gene Ther. 2005 Mar;16(3):348-60. doi: 10.1089/hum.2005.16.348.
7
Spinning molecular immunology into successful immunotherapy.将旋转分子免疫学转化为成功的免疫疗法。
Nat Rev Immunol. 2002 Apr;2(4):227-38. doi: 10.1038/nri774.
8
[Cellular immunotherapy with genetically engineered T-cell therapy for malignancies].[用于恶性肿瘤的基因工程T细胞疗法的细胞免疫疗法]
Rinsho Ketsueki. 2011 May;52(5):243-55.
9
Recognition of tumor glycans by antigen-presenting cells.抗原呈递细胞对肿瘤聚糖的识别。
Curr Opin Immunol. 2006 Feb;18(1):105-11. doi: 10.1016/j.coi.2005.11.001. Epub 2005 Nov 21.
10
Paracrine cytokine adjuvants in cancer immunotherapy.癌症免疫治疗中的旁分泌细胞因子佐剂。
Annu Rev Immunol. 1995;13:399-415. doi: 10.1146/annurev.iy.13.040195.002151.
引用本文的文献
1
(Patho)Physiology of Glycosylphosphatidylinositol-Anchored Proteins II: Intercellular Transfer of Matter (Inheritance?) That Matters.糖基磷脂酰肌醇锚定蛋白的病理生理学 II：物质的细胞间转移（遗传？）至关重要。
Biomolecules. 2023 Jun 15;13(6):994. doi: 10.3390/biom13060994.
2
Targeting the B7 family of co-stimulatory molecules: successes and challenges.靶向共刺激分子 B7 家族：成功与挑战。
BioDrugs. 2013 Feb;27(1):1-13. doi: 10.1007/s40259-012-0001-6.
3
Killer artificial antigen-presenting cells: the synthetic embodiment of a 'guided missile'.杀伤性人工抗原呈递细胞：“制导导弹”的合成体现。
Immunotherapy. 2010 Jul;2(4):539-50. doi: 10.2217/imt.10.26.
4
New designs for cancer vaccine and artificial veto cells: an emerging palette of protein paints.癌症疫苗和人工否决细胞的新设计：一种新兴的蛋白质“颜料”组合。
Immunol Res. 2003;27(2-3):565-74. doi: 10.1385/IR:27:2-3:565.
5
6
Molecular analysis of premalignant and carcinoma in situ lesions of the human breast.人乳腺癌前病变和原位癌的分子分析
Am J Pathol. 1996 Sep;149(3):733-8.
本文引用的文献
1
Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide.自身免疫性lpr/lpr小鼠的成熟T细胞在抗原刺激下的自杀过程中存在缺陷。
Proc Natl Acad Sci U S A. 1993 May 15;90(10):4409-13. doi: 10.1073/pnas.90.10.4409.
2
Prospects for anti-rejection therapies based upon CD8-dependent immunoregulation.
Kidney Int Suppl. 1993 Jan;39:S120-3.
3
The use of palmitate-conjugated protein A for coating cells with artificial receptors which facilitate intercellular interactions.
J Immunol Methods. 1993 Jan 14;158(1):57-65. doi: 10.1016/0022-1759(93)90258-9.
4
Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA.通过表达反义胰岛素样生长因子I RNA的免疫原性C6细胞治疗和预防大鼠胶质母细胞瘤
Science. 1993 Jan 1;259(5091):94-7. doi: 10.1126/science.8418502.
5
Peripheral T cell activation and deletion induced by transfer of lymphocyte subsets expressing endogenous or exogenous mouse mammary tumor virus.表达内源性或外源性小鼠乳腺肿瘤病毒的淋巴细胞亚群转移所诱导的外周T细胞激活与缺失
J Exp Med. 1993 May 1;177(5):1359-66. doi: 10.1084/jem.177.5.1359.
6
Genetically engineered vaccines. Comparison of active versus passive immunotherapy against solid tumors.
Ann N Y Acad Sci. 1993 Aug 12;690:244-55. doi: 10.1111/j.1749-6632.1993.tb44013.x.
7
The structure and biosynthesis of glycosyl phosphatidylinositol protein anchors.糖基磷脂酰肌醇蛋白锚的结构与生物合成
Annu Rev Biochem. 1993;62:121-38. doi: 10.1146/annurev.bi.62.070193.001005.
8
Cognate peptide-induced destruction of CD8+ cytotoxic T lymphocytes is due to fratricide.同源肽诱导的CD8 + 细胞毒性T淋巴细胞破坏是由于自相残杀。
J Immunol. 1993 Jul 15;151(2):658-67.
9
Tumor cells transfected with a bacterial heat-shock gene lose tumorigenicity and induce protection against tumors.用细菌热休克基因转染的肿瘤细胞失去致瘤性并诱导对肿瘤的保护作用。
J Exp Med. 1993 Jul 1;178(1):343-8. doi: 10.1084/jem.178.1.343.
10
Levels of peripheral T cell tolerance induced by different doses of tolerogen.不同剂量耐受原诱导的外周T细胞耐受水平。
Science. 1994 Feb 4;263(5147):674-6. doi: 10.1126/science.8303275.
Zotero 插件